Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
18.86
-0.13 (-0.68%)
Aug 10, 2026, 4:00 PM EDT - Market closed
AAPG Revenue
In the year 2025, Ascentage Pharma Group International had annual revenue of 574.12M CNY, down -41.46%. Ascentage Pharma Group International had revenue of 340.42M in the half year ending December 31, 2025, with 329.37% growth.
Revenue (ttm)
574.12M CNY
Revenue Growth
-41.46%
P/S Ratio
20.76
Revenue / Employee
748,527 CNY
Employees
767
Market Cap
1.70B USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 574.12M | -406.53M | -41.46% |
| Dec 31, 2024 | 980.65M | 758.67M | 341.77% |
| Dec 31, 2023 | 221.98M | 12.27M | 5.85% |
| Dec 31, 2022 | 209.71M | 181.80M | 651.38% |
| Dec 31, 2021 | 27.91M | 15.46M | 124.18% |
| Dec 31, 2020 | 12.45M | -2.06M | -14.21% |
| Dec 31, 2019 | 14.51M | 7.71M | 113.21% |
| Dec 31, 2018 | 6.81M | 479.00K | 7.57% |
| Dec 31, 2017 | 6.33M | -1.34M | -17.46% |
| Dec 31, 2016 | 7.67M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Fortrea Holdings | 2.68B |
| Sarepta Therapeutics | 1.97B |
| Lakefront Biotherapeutics NV | 1.20B |
| Immunocore Holdings | 430.78M |
| AnaptysBio | 232.39M |
| Maravai LifeSciences Holdings | 208.78M |
| Septerna | 72.26M |
| Intellia Therapeutics | 59.51M |
AAPG News
- 5 days ago - CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026 - GlobeNewsWire
- 5 days ago - Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026 - GlobeNewsWire
- 7 days ago - Ascentage Appoints Miyara As CBO And Ziegler As COO To Support Global Expansion - Nasdaq
- 8 days ago - Ascentage Pharma appoints Miyara as CBO, Ziegler as CCO - TheFly
- 8 days ago - Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer - GlobeNewsWire
- 15 days ago - Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026 - GlobeNewsWire
- 21 days ago - Ascentage Pharma files to sell American Depositary Shares, no amount given - TheFly
- 2 months ago - Ascentage Pharma assumed with an Outperform at Oppenheimer - TheFly